| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | F Mornex | |
| N Girard | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| adaptive radiation therapy | Q180507 | ||
| P304 | page(s) | 1743-1747 | |
| P577 | publication date | 2006-06-09 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art. | |
| P478 | volume | 17 |
| Q46108882 | A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401. |
| Q43000162 | Dose escalation of gemcitabine concomitant with radiation and cisplatin for nonsmall cell lung cancer: a phase 1-2 study |
| Q91831816 | Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p |
| Q98159089 | MicroRNA-147 targets BDNF to inhibit cell proliferation, migration and invasion in non-small cell lung cancer |
| Q37038352 | Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents |
| Q41634276 | PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma |
| Q38763415 | Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma |
| Q37327880 | Preclinical absorption, distribution, metabolism, and excretion of an oral amide prodrug of gemcitabine designed to deliver prolonged systemic exposure |
| Q84582196 | Radiotherapy for locally advanced non-small cell lung cancer |
| Q60053980 | The Hsp70 co-chaperone Ydj1/HDJ2 regulates ribonucleotide reductase activity |
Search more.